Smruthi Organics Ltd (SMRUTHIORG) — shareholding pattern, promoter holding, financials and share price
About Smruthi Organics Ltd (SMRUTHIORG)
Smruthi Organics Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as SMRUTHIORG and on the BSE under scrip code 540686. Its ISIN is INE172E01011.
Incorporated in 1989, Smruthi Organics Ltd is a manufacturer of Active Pharmaceutical Ingredients [1]
Smruthi Organics Limited specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) focusing on anti-diabetic, anti-hypertension, and anti-infectives categories. They cater to a global clientele across Asia, Americas, and Africa.
The company operates two manufacturing facilities in Solapur, India, and has progressively expanded its product offerings since its incorporation in 1989.
Listed peers in Pharmaceuticals: Quest Laboratories Ltd, Natural Capsules Ltd, Kimia Biosciences Ltd, Alpa Laboratories Ltd, Bal Pharma Ltd, Lactose (India) Ltd.
Valuation & Returns
10 Jul 2026At ₹122.2 a share on 10 Jul 2026, Smruthi Organics Ltd (SMRUTHIORG) was valued at a price-to-earnings ratio of 40.78x against an industry P/E of 36.41x and a price-to-book of 1.95x on a book value of ₹62.58 per share as of Mar 2025. Solomo computes return on equity of 4.79% and return on capital employed of 7.18% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 40.78x
- Industry P/E
- 36.41x
- P/B
- 1.95x
- EPS (TTM)
- ₹3
- Book value / share
- ₹62.58
- ROE
- 4.79%
- ROCE
- 7.18%
- ROA
- 3.07%
- Debt / equity
- 0.23x
- Dividend yield
- 1.23%
- EBITDA margin
- 12.45%
- 52-week range
- ₹95 – ₹164
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Smruthi Organics Ltd (SMRUTHIORG) reported revenue of ₹102 crore, net profit of ₹3 crore and earnings per share of ₹3. That compares with revenue of ₹126 crore and net profit of ₹4 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹29.09 crore and net profit ₹1.07 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 133 | 141 | 128 | 126 | 102 |
| Net profit (₹ cr) | 10 | 4 | 4 | 4 | 3 |
| EPS (₹) | 9.07 | 3.61 | 3.14 | 3.11 | 3 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 5.54% | -0.79% | -1.88% | -1.28% |
| Profit growth | 19.38% | -15.86% | -29.99% | -0.84% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 64.73% of Smruthi Organics Ltd (SMRUTHIORG) (unchanged from the previous quarter). Market capitalisation was ₹140 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2017.
Largest disclosed public shareholders in Jun 2026: SMITHA GUPTA 1.21%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 64.73% | - | - | - | 35.27% |
| Mar 2026 | 64.73% | - | - | - | 35.27% |
| Dec 2025 | 64.73% | - | - | - | 35.27% |
| Sep 2025 | 64.73% | - | - | - | 35.27% |
| Jun 2025 | 64.73% | - | - | - | 35.27% |
| Mar 2025 | 64.73% | - | - | - | 35.27% |
| Dec 2024 | 63.87% | - | - | - | 36.13% |
| Sep 2024 | 63.87% | - | - | - | 36.13% |